Attachment
Gates Package, p.1028 · gates:exh:00438
Page text: p.1028 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
- Topics
- Vaccines
This system eventually stops the first attack of a virus and allows your body to do a better
job the next time it sees that virus. . But for viruses that make you sick--like COVID or
influenza--it's better to prime your immune system so it can attack the virus the first time it
shows up. That's what vaccines do.
Conventional vaccines operate by injecting a weakened or dead form of the virus you're
trying to stop. Your immune system sees the new shapes on the virus, kicks into gear, and builds
up immunity. With a weakened virus, there is always the question of whether it was weakened
enough--if it wasn't, it might mutate back into a form that can cause disease. But if it was
weakened too much, it won't activate a strong immune response in your body. Likewise, killed
viruses often don't trigger much of an immune response.
The idea behind mRNA vaccines was ingenious. Since mRNA takes the orders for
proteins from the DNA and delivers them to the cooks in your cells' kitchen, what if we could
change those orders in a very targeted way? By teaching your cells to make shapes that match
shapes on the actual virus, the vaccine would trigger your immune system without having to
introduce the virus itself.
If they could be made, mRNA vaccines would be a huge advance over conventional
vaccines. Once you had mapped out all the proteins that make up the virus you wanted to target,
you'd identify the one that you want antibodies to grab. Then you'd study the virus's genetic
code to find the instructions for making that protein, and you'd put that code into the vaccine
using mRNA. If, later, you wanted to attack a different protein, you'd just change the mRNA.
This design process would take at most a few weeks. You would ask the waiter for fries instead
of a side salad, and your immune system would do the rest.